C11.0 ICD-10-CM Code: Malignant neoplasm of superior wall of nasopharynx
C11.0 maps to CMS-HCC V28 21. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · HCC coding software
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)
C11.0
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMalignant neoplasm of superior wall of nasopharynx
Cancer located in the upper wall of the nasopharynx, the uppermost part of the throat behind the nose.

Buddy Insight
Malignant neoplasm of the superior wall of the nasopharynx involves cancer of the roof of the upper throat behind the nose, near the base of the skull.
CMS-HCC V28
MappedHCC 21
Coefficient HCC 21: 0.671 (Community Non-Dual Aged (CNA))
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 011
Code-level coefficient reference
ESRD/PACE
MappedHCC 11
Code-level coefficient reference
RXHCC
N/A—
Not mapped
Code Book Path
Inclusion Terms
Official- Malignant neoplasm of roof of nasopharynx
Excludes 2
OfficialNo Excludes 2 notes are included in this display for C11.0. Check the code and parent instructions in the Code Book.
Related Codes
Includes
OfficialNo Includes notes are included in this display for C11.0. Check the code and parent instructions in the Code Book.
Excludes 1
OfficialNo Excludes 1 notes are included in this display for C11.0. Check the code and parent instructions in the Code Book.
Code First
OfficialNo Code First sequencing instructions are included in this display for C11.0. Check the code and parent instructions in the Code Book.
Use Additional
Official- code to identify:Inherited from C11
- exposure to environmental tobacco smoke (Z77.22)Inherited from C11
- exposure to tobacco smoke in the perinatal period (P96.81)Inherited from C11
- history of tobacco dependence (Z87.891)Inherited from C11
- occupational exposure to environmental tobacco smoke (Z57.31)Inherited from C11
- tobacco dependence (F17.-)Inherited from C11
- tobacco use (Z72.0)Inherited from C11
Code Also
OfficialNo Code Also instructions are included in this display for C11.0. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C11.0 an HCC code?
Yes. C11.0 (Malignant neoplasm of superior wall of nasopharynx) maps to HCC 21, Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.671. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: C11.0 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C11.0
- Description
- Malignant neoplasm of superior wall of nasopharynx
- HCC (V28)
- HCC 21 — Lymphoma and Other Cancers
- RAF reference coefficient
- 0.671
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work C11.0 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for C11.0
For C11.0, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C11.0 is the ICD-10-CM diagnosis code for malignant neoplasm of superior wall of nasopharynx. Cancer located in the upper wall of the nasopharynx, the uppermost part of the throat behind the nose. C11.0 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lip, oral cavity and pharynx (c00-c14).
Under the CMS-HCC V28 risk adjustment model, C11.0 maps to Lymphoma and Other Cancers (HCC 21) with a source-labeled community, non-dual, aged reference coefficient of 0.671. No V24 mapping is shown for C11.0; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
The superior wall of the nasopharynx is the roof or top surface of the nasopharynx, near the base of the skull. For C11.0, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C11.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
Clinical Significance
Malignant neoplasm of the superior wall of the nasopharynx involves cancer of the roof of the upper throat behind the nose, near the base of the skull. This is clinically significant because proximity to the skull base means early intracranial extension risk, and nasopharyngeal cancers are strongly associated with Epstein-Barr virus in endemic populations.
Documentation Requirements
- ✓Pathology-confirmed malignancy with histological type (nonkeratinizing carcinoma common in EBV-associated cases)
- ✓Specific documentation of superior wall or roof of nasopharynx as primary site
- ✓EBV serology and tumor EBV-encoded RNA (EBER) status
- ✓MRI assessment of skull base invasion
- ✓TNM staging per nasopharyngeal cancer-specific staging criteria
Commonly Confused Codes
- •C11.1: Posterior wall of nasopharynx; the superior wall (roof) is distinct from the posterior (back) wall
- •C11.2: Lateral wall of nasopharynx; distinguish roof from side walls
- •C11.8: Overlapping sites of nasopharynx; use when tumor spans multiple nasopharyngeal walls
- •C30.0: Nasal cavity; nasopharyngeal tumors may extend anteriorly into the nasal cavity

